Bronchopleural fistulas (BPFs) carry significant morbidity (1,2) and mortality. Although surgery remains the cornerstone of care, no standard therapeutic approach to the management of BPFs has been established. Different BPF sizes and anatomical locations, along with variability in patient comorbidities often mandate conservative therapeutic strategies (1,3). The use of endobronchial stents has been described as an alternative when surgical approaches are limited (4,5). Stents protect the contralateral lung from spillage while allowing time for the BPF to heal.